{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:14:00Z","timestamp":1784124840609,"version":"3.55.0"},"reference-count":29,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.1536\/ihj.23-058","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T22:17:24Z","timestamp":1706653044000},"page":"4-12","source":"Crossref","is-referenced-by-count":6,"title":["Association Between Serum Uric Acid Levels and Neoatherosclerosis"],"prefix":"10.1536","volume":"65","author":[{"given":"Ning","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangya","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranzun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Hospital of Zunyi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Otsuka F, Byrne RA, Yahagi K, <i>et al<\/i>. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J 2015; 36: 2147-59.","DOI":"10.1093\/eurheartj\/ehv205"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Joo HJ, Jeong HS, Kook H, <i>et al<\/i>. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis. BMC Cardiovasc Disord 2018; 18: 114.","DOI":"10.1186\/s12872-018-0840-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cantor JR, Abu-Remaileh M, Kanarek N, <i>et al<\/i>. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell 2017; 169: 258-272.e17.","DOI":"10.1016\/j.cell.2017.03.023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Li X, Meng X, Timofeeva M, <i>et al<\/i>. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ 2017; 357: j2376.","DOI":"10.1136\/bmj.j2376"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhang D, Zhang R, Wang N, Lin L, Yu B. Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: A 3-vessel optical coherence tomography study. BioMed Res Int 2018; 2018: 7919165.","DOI":"10.1155\/2018\/7919165"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Taniwaki M, Radu MD, Zaugg S, <i>et al<\/i>. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation 2016; 133: 650-60.","DOI":"10.1161\/CIRCULATIONAHA.115.019071"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lal BK, Kaperonis EA, Cuadra S, Kapadia I, Hobson RW 2nd. Patterns of in-stent restenosis after carotid artery stenting: classification and implications for long-term outcome. J Vasc Surg 2007; 46: 833-40.","DOI":"10.1016\/j.jvs.2007.07.022"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Xhepa E, Byrne RA, Rivero F, <i>et al<\/i>. Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis. Clin Res Cardiol 2019; 108: 1059-68.","DOI":"10.1007\/s00392-019-01439-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nishino S, Sakuma M, Kanaya T, <i>et al<\/i>. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density. Int J Cardiovasc Imaging 2019; 35: 1971-8.","DOI":"10.1007\/s10554-019-01651-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hoshino M, Yonetsu T, Usui E, <i>et al<\/i>. Clinical significance of the presence or absence of lipid-rich plaque underneath intact fibrous cap plaque in acute coronary syndrome. J Am Heart Assoc 2019; 8: e011820.","DOI":"10.1161\/JAHA.118.011820"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sluijs I, Beulens JW, van der A DL, Spijkerman AM, Schulze MB, van der Schouw YT. Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr 2013; 143: 80-5.","DOI":"10.3945\/jn.112.167221"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Turak O, Canpolat U, \u00d6zcan F, <i>et al<\/i>. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents. Am J Cardiol 2014; 113: 197-202.","DOI":"10.1016\/j.amjcard.2013.09.004"},{"key":"13","unstructured":"13. Wang JL, Qin Z, Wang ZJ, <i>et al<\/i>. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent. J Geriatr Cardiol 2018; 15: 137-45."},{"key":"14","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.4244\/EIJ-D-20-00662","volume":"17","year":"2021","unstructured":"14. Xhepa E, Bresha J, Joner M, <i>et al<\/i>. Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis. EuroIntervention 2021; 17: e388-95.","journal-title":"EuroIntervention","ISSN":"https:\/\/id.crossref.org\/issn\/1774-024X","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ali ZA, Roleder T, Narula J, <i>et al<\/i>. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv 2013; 6: 507-17.","DOI":"10.1161\/CIRCINTERVENTIONS.112.000248"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Prati F, Romagnoli E, Gatto L, <i>et al<\/i>. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J 2020; 41: 383-91.","DOI":"10.1093\/eurheartj\/ehz520"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Xing L, Higuma T, Wang Z, <i>et al<\/i>. Clinical significance of lipid-rich plaque detected by optical coherence tomography: A 4-year follow-up study. J Am Coll Cardiol 2017; 69: 2502-13.","DOI":"10.1016\/S0735-1097(17)34364-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chu X, Lu Y, Mei M, <i>et al<\/i>. Correlation between serum uric acid levels and coronary plaque characteristics on optical coherence tomography. Int Heart J 2022; 63: 806-13.","DOI":"10.1536\/ihj.21-826"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010; 62: 170-80.","DOI":"10.1002\/acr.20065"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Magnoni M, Berteotti M, Ceriotti F, <i>et al<\/i>. Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. Int J Cardiol 2017; 240: 25-9.","DOI":"10.1016\/j.ijcard.2017.04.027"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lopez-Pineda A, Cordero A, Carratala-Munuera C, <i>et al<\/i>. Hyperuricemia as a prognostic factor after acute coronary syndrome. Atherosclerosis 2018; 269: 229-35.","DOI":"10.1016\/j.atherosclerosis.2018.01.017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kobayashi N, Hata N, Tsurumi M, <i>et al<\/i>. Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to serum uric acid levels in patients with acute coronary syndrome. Am J Cardiol 2018; 122: 17-25.","DOI":"10.1016\/j.amjcard.2018.03.022"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Kobayashi N, Asai K, Tsurumi M, <i>et al<\/i>. Impact of accumulated serum uric acid on coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes in patients with acute coronary syndrome. Cardiology 2018; 141: 190-8.","DOI":"10.1159\/000496053"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: A clinical review. J Cardiol 2021; 78: 51-7.","DOI":"10.1016\/j.jjcc.2020.12.013"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Agnoletti D, Cicero AFG, Borghi C. The impact of uric acid and hyperuricemia on cardiovascular and renal systems. Cardiol Clin 2021; 39: 365-76.","DOI":"10.1016\/j.ccl.2021.04.009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Katsiki N, Dimitriadis GD, Mikhailidis DP. Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. Curr Pharm Des 2021; 27: 1941-51.","DOI":"10.2174\/1381612827666210104124320"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Kanellis J, Watanabe S, Li JH, <i>et al<\/i>. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-93.","DOI":"10.1161\/01.HYP.0000072820.07472.3B"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lyngdoh T, Marques-Vidal P, Paccaud F, <i>et al<\/i>. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLOS ONE 2011; 6: e19901.","DOI":"10.1371\/journal.pone.0019901"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-62.","DOI":"10.1681\/ASN.2005050572"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-058\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T04:10:33Z","timestamp":1706933433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-058\/_article"}},"subtitle":["An Optical Coherence Tomography Study in Patients with In-Stent Restenosis"],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-058","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"article-number":"23-058"}}